Do you want to read an article? Please log in or register.
Severe toxicity-free survival following acute lymphoblastic leukemia in patients aged 1-45 years: a Danish cohort study
Leukemia
Related content
Leukemia
Prognostic factors and survival outcomes of first CNS relapse in childhood acute lymphoblastic leukemia: results from the ALL-IC REL 2016 study
Leuk Lymphoma
Hazar V, Makiya M, Yalçın K, Cadiu JT, Manni F, Reyes Barragan A, Polychronopoulou S, Colita A, Avramova B, Kavcic M, Ampatzidou M, Radu LE, Hristova T, Prelog T, Höbör B, Farah R, Jazbec J, Erdelyi DJ
doi: 10.1080/10428194.2025.2598861
Head and Neck Cancer
Evaluation of progression-free status at 24 months as a surrogate endpoint for overall survival in patients with human papillomavirus-positive oropharyngeal cancer: a retrospective cohort study
Lancet Oncol
Cao C, Sherman EJ, Riaz N, McBride SM, Yu Y, Shamseddine A, Wong W, Dunn LA, Ho AL, Wong RJ, Lee NY
doi: 10.1016/S1470-2045(25)00649-7
RECOMMENDED
Breast Cancer
Extended Endocrine Therapy Following 5 Years of Adjuvant Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal Patients With Node-Positive, Hormone Receptor-Positive Breast Cancer: A Cohort Study
★ 1
Recommended by
Dr Andreas Müller, Faculty Member
J Clin Oncol
Valenza C, Zheng Y, Milano M, Trapani D, Giordano E, Guidi L, Berton Giachetti PPM, Boldrini L, Castellano G, Katrini J, Malagutti B, Antonarelli G, Conforti F, Pagan E, Bagnardi V, Kirkner GJ, Sangalli C, Dibble KE, Colleoni M, Regan MM, Munzone E, Curigliano G, Partridge AH
doi: 10.1200/JCO-25-01660
Genitourinary Cancer
Oncological Outcomes of Non-Muscle Invasive Bladder Cancer in Patients Aged ≤45: A Retrospective Matched Cohort Study
J Urol
St-Laurent MP, Din S, Moryousef J, Lajkosz K, Kwong JCC, Chan A, Kim J, Taborek A, Chadee A, Sadri I, Reznik G, Tin C, Fleshner NE, Kulkarni GS, Black PC, Kassouf W, Zlotta AR
doi: 10.1097/JU.0000000000005183
Leukemia
Similar Outcome With Haploidentical, Matched Sibling, or Matched Unrelated Donor Hematopoietic Cell Transplantation for Adult Patients With Adverse-Risk TP53-Mutated Acute Myeloid Leukemia in First Remission: A Comparative Study From the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Am J Hematol
Ru Y, Chen J, Ferhat AT, Labussière-Wallet H, Gedde-Dahl T, Kröger N, Socié G, Yakoub-Agha I, Eder M, Mielke S, Wu D, Mohty M, Ciceri F, Gorin NC
doi: 10.1002/ajh.70069
Lymphoma
Improved progression free survival after axicabtagene ciloleucel compared to tisagenlecleucel, in patients aged >70 years with large B-cell lymphoma
Haematologica
Rocha V, Mooyaart JE, Ram R, Clesham K, Daskalakis M, Huynh A, Potter V, Chaganti S, Gabellier L, Tholouli E, Collin M, Nicholson E, Protheroe R, Passweg J, Ayuk F, Schneidawind D, Kwon M, Corral LL, Zeiser R, Scheid C, Yakoub-Agha I, Dreger P, Stolzel F, Hoogenboom J, Coelho MHM, Tomas AA, Malard F, Kuball J, Sureda A, Barzabachi A, Ruggeri A
doi: 10.3324/haematol.2026.300508
Lung, Respiratory and Thoracic Cancer
Patient-reported EORTC QLQ C-30 global health status decline predicts survival after video-assisted thoracoscopic (VATS) lung resection and stereotactic ablative radiotherapy (SABR): A 5 year follow-up from the Lilac study
Lung Cancer
Pompili C, Jaques L, Callister MEJ, Franks KN, Brunelli A, Velikova G
doi: 10.1016/j.lungcan.2026.109335
ASH 2025
Lymphoma
TRANSCEND FL: High rates of deep and durable responses and sustained survival with liso-cel in patients with R/R FL after three years of follow-up
Leukemia
Predictors of survival in adults with B-cell acute lymphoblastic leukemia treated with blinatumomab and/or inotuzumab ozogamicin in first salvage
Leukemia
Azevedo RS, Jabbour E, Jain N, Haddad FG, Kebriaei P, Khouri I, Shpall EJ, Champlin R, Karrar O, Maroun M, Senapati J, Kugler E, Garris RS, Ravandi F, Kantarjian H, Short NJ
doi: 10.1038/s41375-026-03056-4